The variant of the fat-dissolving injection that I use off-label in my practice in Munich contains a compound developed by the Lipolysis Department of Network Global Health, a global association of physicians. It is a combination of phosphatidylcholine (PPC) and deoxycholic acid (DOC). The FDA-approved medication KYBELLA (Allergan) and the medical device AQUALYX (Marllor Biomedical) have introduced alternative formulations on the market that solely rely on DOC as the active component. Treatment protocols as well as achievable results, by my judgement, are similar to the fat-melting treatment described in this article.